Yasmeen Rahimi
Stock Analyst at Piper Sandler
(3.65)
# 737
Out of 4,873 analysts
83
Total ratings
38.27%
Success rate
10.57%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yasmeen Rahimi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRNA Verona Pharma | Maintains: Overweight | $76 → $160 | $97.82 | +63.57% | 3 | Jun 23, 2025 | |
| TVRD Tvardi Therapeutics | Initiates: Overweight | $78 | $27.09 | +187.98% | 1 | Jun 12, 2025 | |
| PRTA Prothena Corporation | Maintains: Overweight | $110 → $81 | $6.14 | +1,219.22% | 3 | May 27, 2025 | |
| SLNO Soleno Therapeutics | Maintains: Overweight | $93 → $145 | $83.33 | +74.01% | 2 | Apr 24, 2025 | |
| EWTX Edgewise Therapeutics | Maintains: Overweight | $51 | $14.84 | +243.78% | 4 | Apr 2, 2025 | |
| LXRX Lexicon Pharmaceuticals | Maintains: Overweight | $10 → $6 | $0.77 | +680.13% | 2 | Mar 7, 2025 | |
| AVTX Avalo Therapeutics | Initiates: Overweight | $48 | $4.93 | +873.63% | 1 | Feb 28, 2025 | |
| DRUG Bright Minds Biosciences | Initiates: Overweight | $93 | $27.33 | +240.29% | 1 | Jan 23, 2025 | |
| UPB Upstream Bio | Initiates: Overweight | $75 | $11.44 | +555.59% | 1 | Nov 5, 2024 | |
| NKTR Nektar Therapeutics | Initiates: Overweight | $105 | $26.55 | +295.48% | 1 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $52 → $26 | $9.21 | +182.46% | 2 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $37 | $18.46 | +100.43% | 2 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 | $1.18 | +2,103.39% | 2 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $28 | $0.72 | +3,773.82% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $97 | $31.32 | +209.71% | 4 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $270 | $43.83 | +516.02% | 3 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $76 | $20.16 | +276.98% | 1 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 | $7.08 | +253.36% | 3 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $30 | $14.66 | +104.71% | 1 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $6 → $12 | $4.00 | +200.00% | 2 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $90 | $6.94 | +1,196.83% | 1 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $180 | $12.60 | +1,329.14% | 2 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 | $1.36 | +1,002.94% | 1 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $336 | $286.52 | +17.27% | 3 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $16 | $2.29 | +598.69% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $80 | $23.30 | +243.42% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $58 → $93 | $22.25 | +317.98% | 3 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $65 | $17.00 | +282.47% | 1 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $57 | $16.08 | +254.48% | 2 | Oct 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $67 | $10.00 | +570.34% | 1 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $35 | $53.51 | -34.59% | 3 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $87 | $7.39 | +1,077.27% | 3 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $75 → $175 | $8.60 | +1,934.88% | 4 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $50 → $72 | $33.65 | +113.97% | 5 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $63 → $27 | $1.30 | +1,976.92% | 1 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $54 → $19 | $9.79 | +94.08% | 2 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $50 | $2.46 | +1,932.52% | 1 | Nov 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $40 | $0.62 | +6,315.40% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $18 | $0.56 | +3,114.29% | 1 | Jun 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $420 | $16.30 | +2,476.69% | 1 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $77 | $13.40 | +474.63% | 1 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $77 | $50.60 | +52.17% | 1 | Jul 31, 2020 |
Verona Pharma
Jun 23, 2025
Maintains: Overweight
Price Target: $76 → $160
Current: $97.82
Upside: +63.57%
Tvardi Therapeutics
Jun 12, 2025
Initiates: Overweight
Price Target: $78
Current: $27.09
Upside: +187.98%
Prothena Corporation
May 27, 2025
Maintains: Overweight
Price Target: $110 → $81
Current: $6.14
Upside: +1,219.22%
Soleno Therapeutics
Apr 24, 2025
Maintains: Overweight
Price Target: $93 → $145
Current: $83.33
Upside: +74.01%
Edgewise Therapeutics
Apr 2, 2025
Maintains: Overweight
Price Target: $51
Current: $14.84
Upside: +243.78%
Lexicon Pharmaceuticals
Mar 7, 2025
Maintains: Overweight
Price Target: $10 → $6
Current: $0.77
Upside: +680.13%
Avalo Therapeutics
Feb 28, 2025
Initiates: Overweight
Price Target: $48
Current: $4.93
Upside: +873.63%
Bright Minds Biosciences
Jan 23, 2025
Initiates: Overweight
Price Target: $93
Current: $27.33
Upside: +240.29%
Upstream Bio
Nov 5, 2024
Initiates: Overweight
Price Target: $75
Current: $11.44
Upside: +555.59%
Nektar Therapeutics
Nov 4, 2024
Initiates: Overweight
Price Target: $105
Current: $26.55
Upside: +295.48%
Oct 30, 2024
Reiterates: Overweight
Price Target: $52 → $26
Current: $9.21
Upside: +182.46%
Sep 23, 2024
Reiterates: Overweight
Price Target: $37
Current: $18.46
Upside: +100.43%
Sep 19, 2024
Maintains: Overweight
Price Target: $26
Current: $1.18
Upside: +2,103.39%
Jul 16, 2024
Reiterates: Overweight
Price Target: $28
Current: $0.72
Upside: +3,773.82%
Jul 2, 2024
Maintains: Overweight
Price Target: $97
Current: $31.32
Upside: +209.71%
Jul 1, 2024
Maintains: Overweight
Price Target: $270
Current: $43.83
Upside: +516.02%
Jun 26, 2024
Initiates: Overweight
Price Target: $76
Current: $20.16
Upside: +276.98%
Jun 21, 2024
Maintains: Overweight
Price Target: $25
Current: $7.08
Upside: +253.36%
Jun 13, 2024
Initiates: Overweight
Price Target: $30
Current: $14.66
Upside: +104.71%
May 7, 2024
Upgrades: Overweight
Price Target: $6 → $12
Current: $4.00
Upside: +200.00%
Apr 4, 2024
Initiates: Overweight
Price Target: $90
Current: $6.94
Upside: +1,196.83%
Mar 27, 2024
Maintains: Overweight
Price Target: $180
Current: $12.60
Upside: +1,329.14%
Mar 27, 2024
Maintains: Overweight
Price Target: $15
Current: $1.36
Upside: +1,002.94%
Mar 14, 2024
Reiterates: Overweight
Price Target: $336
Current: $286.52
Upside: +17.27%
Mar 4, 2024
Maintains: Overweight
Price Target: $7 → $16
Current: $2.29
Upside: +598.69%
Feb 16, 2024
Initiates: Overweight
Price Target: $80
Current: $23.30
Upside: +243.42%
Oct 27, 2023
Maintains: Overweight
Price Target: $58 → $93
Current: $22.25
Upside: +317.98%
Oct 25, 2023
Initiates: Overweight
Price Target: $65
Current: $17.00
Upside: +282.47%
Oct 24, 2023
Maintains: Overweight
Price Target: $28 → $57
Current: $16.08
Upside: +254.48%
Aug 8, 2023
Initiates: Overweight
Price Target: $67
Current: $10.00
Upside: +570.34%
Jul 3, 2023
Reiterates: Overweight
Price Target: $35
Current: $53.51
Upside: -34.59%
Feb 8, 2023
Maintains: Overweight
Price Target: $87
Current: $7.39
Upside: +1,077.27%
Jan 17, 2023
Maintains: Overweight
Price Target: $75 → $175
Current: $8.60
Upside: +1,934.88%
Jun 10, 2022
Maintains: Overweight
Price Target: $50 → $72
Current: $33.65
Upside: +113.97%
May 18, 2022
Maintains: Overweight
Price Target: $63 → $27
Current: $1.30
Upside: +1,976.92%
May 18, 2022
Maintains: Overweight
Price Target: $54 → $19
Current: $9.79
Upside: +94.08%
Nov 15, 2021
Initiates: Overweight
Price Target: $50
Current: $2.46
Upside: +1,932.52%
Aug 24, 2021
Initiates: Overweight
Price Target: $40
Current: $0.62
Upside: +6,315.40%
Jun 11, 2021
Initiates: Overweight
Price Target: $18
Current: $0.56
Upside: +3,114.29%
Aug 26, 2020
Initiates: Overweight
Price Target: $420
Current: $16.30
Upside: +2,476.69%
Aug 26, 2020
Initiates: Overweight
Price Target: $77
Current: $13.40
Upside: +474.63%
Jul 31, 2020
Initiates: Overweight
Price Target: $77
Current: $50.60
Upside: +52.17%